INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
Mayo Clinic
Pharmacyclics LLC.
Pharmacyclics LLC.
Ohio State University Comprehensive Cancer Center
Pharmacyclics LLC.
Pharmacyclics LLC.
Pharmacyclics LLC.
Pharmacyclics LLC.
Pharmacyclics LLC.